CLOVER HEALTH INVESTMENTS CO's ticker is CLOV and the CUSIP is 18914F103. A total of 176 filers reported holding CLOVER HEALTH INVESTMENTS CO in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $310,693 | +191.5% | 287,679 | +128.1% | 0.07% | +97.1% |
| Q1 2023 | $106,589 | -41.1% | 126,126 | -35.2% | 0.03% | -43.3% |
| Q4 2022 | $180,868 | +41.3% | 194,586 | +158.5% | 0.06% | -4.8% |
| Q3 2022 | $128,000 | +178.3% | 75,270 | +254.0% | 0.06% | +125.0% |
| Q2 2022 | $46,000 | – | 21,262 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hudson Structured Capital Management Ltd. | 1,973,944 | $7,008,000 | 16.49% |
| Lee Financial Group Hawaii, Inc. | 85 | $24,000,000 | 16.36% |
| Summit Rock Advisors, LP | 210,639 | $748,000 | 0.46% |
| CTC Capital Management, LLC | 30,800 | $109,000 | 0.29% |
| SAGE RHINO CAPITAL LLC | 261,500 | $928,000 | 0.28% |
| University of Massachusetts Foundation, Inc. | 70,049 | $249,000 | 0.23% |
| EQUITEC PROPRIETARY MARKETS, LLC | 161,757 | $574,000 | 0.13% |
| Gainplan LLC | 45,767 | $162,000 | 0.12% |
| Bayesian Capital Management, LP | 211,500 | $751,000 | 0.11% |
| Perceptive Advisors | 1,500,000 | $5,325,000 | 0.11% |